Price T Rowe Associates Inc. MD increased its holdings in shares of SiriusPoint Ltd. (NYSE:SPNT - Free Report) by 481.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 317,560 shares of the company's stock after purchasing an additional 262,981 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.20% of SiriusPoint worth $5,206,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Capital Research Global Investors lifted its position in shares of SiriusPoint by 17.8% in the fourth quarter. Capital Research Global Investors now owns 6,300,000 shares of the company's stock worth $103,257,000 after buying an additional 950,000 shares in the last quarter. Donald Smith & CO. Inc. increased its stake in SiriusPoint by 12.9% in the 4th quarter. Donald Smith & CO. Inc. now owns 7,887,887 shares of the company's stock worth $129,282,000 after acquiring an additional 900,209 shares during the last quarter. Wellington Management Group LLP raised its holdings in shares of SiriusPoint by 8.5% during the 4th quarter. Wellington Management Group LLP now owns 10,694,214 shares of the company's stock worth $175,278,000 after acquiring an additional 838,262 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of SiriusPoint by 3.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 7,568,197 shares of the company's stock valued at $124,018,000 after acquiring an additional 252,120 shares during the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of SiriusPoint by 9.3% in the fourth quarter. American Century Companies Inc. now owns 2,656,792 shares of the company's stock valued at $43,545,000 after purchasing an additional 226,870 shares in the last quarter. Institutional investors own 52.79% of the company's stock.
Wall Street Analyst Weigh In
SPNT has been the topic of a number of recent research reports. Jefferies Financial Group started coverage on shares of SiriusPoint in a research note on Tuesday, April 15th. They set a "hold" rating and a $17.00 price target on the stock. DOWLING & PARTN raised shares of SiriusPoint from a "hold" rating to a "strong-buy" rating in a report on Thursday, March 6th.
Check Out Our Latest Report on SPNT
Insider Activity at SiriusPoint
In other SiriusPoint news, Director Daniel S. Loeb sold 4,106,631 shares of the company's stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $13.71, for a total value of $56,301,911.01. Following the transaction, the director now owns 9,428,008 shares of the company's stock, valued at $129,257,989.68. This represents a 30.34 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.70% of the stock is currently owned by insiders.
SiriusPoint Trading Down 0.4 %
Shares of SiriusPoint stock traded down $0.07 on Friday, reaching $19.23. The company had a trading volume of 528,402 shares, compared to its average volume of 610,050. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of 20.03 and a beta of 0.81. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.57 and a quick ratio of 0.56. The firm's 50-day moving average price is $16.39 and its two-hundred day moving average price is $15.28. SiriusPoint Ltd. has a 1 year low of $11.92 and a 1 year high of $19.74.
SiriusPoint (NYSE:SPNT - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.26 by $0.23. SiriusPoint had a net margin of 7.68% and a return on equity of 8.73%. The company had revenue of $727.30 million during the quarter, compared to analyst estimates of $688.00 million.
About SiriusPoint
(
Free Report)
SiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services. The Reinsurance segment provides aviation and space, accident and health, casualty, credit, marine and energy, property to insurance and reinsurance companies, government entities, and other risk bearing vehicles.
See Also
Before you consider SiriusPoint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SiriusPoint wasn't on the list.
While SiriusPoint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
